(Total Views: 152)
Posted On: 04/08/2019 1:11:42 AM
Post# of 1040
p, f43? of 10k Note 13 - Subsequent Events
(i) On January 7, 2019, the Company granted options under the 2011 Equity Incentive Plan to one senior officer, to purchase 25,000 shares of Common Stock at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 6, 2029. The fair value of the options at the date of grant amounted to approximately $10,000.
(ii) Approximately $1,715,000 was collected through the Company’s DSPP program during the period January 1, 2019 through February 25, 2019.
(iii) On February 24, 2019 Zion submitted its work plan for 2019 in accordance with the requirement referenced in Note 1 of its 2019 license extension. This work plan was approved on February 28, 2019.
(iv) On February 24, 2019 Zion submitted a request for approval for a license extension through December 2, 2020 on its Megiddo-Jezreel License. Zion received approval on its request for license extension through December 2, 2020 on February 28, 2019.
(i) On January 7, 2019, the Company granted options under the 2011 Equity Incentive Plan to one senior officer, to purchase 25,000 shares of Common Stock at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 6, 2029. The fair value of the options at the date of grant amounted to approximately $10,000.
(ii) Approximately $1,715,000 was collected through the Company’s DSPP program during the period January 1, 2019 through February 25, 2019.
(iii) On February 24, 2019 Zion submitted its work plan for 2019 in accordance with the requirement referenced in Note 1 of its 2019 license extension. This work plan was approved on February 28, 2019.
(iv) On February 24, 2019 Zion submitted a request for approval for a license extension through December 2, 2020 on its Megiddo-Jezreel License. Zion received approval on its request for license extension through December 2, 2020 on February 28, 2019.
(0)
(0)
